Clinical Trials on Severe or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen T in Australia

Total 2 results

  • Novartis Pharmaceuticals
    University of Pennsylvania
    Recruiting
    Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
    United States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
  • Sanford Health
    National Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaborators
    Recruiting
    Mitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditions
    United States, Australia
3
Subscribe